CampbellTeaching

Excess Deaths in the United Kingdom: Midazolam and Euthanasia in the COVID-19 Pandemic https://www.researchgate.net/publication/377266988_Excess_Deaths_in_the_United_Kingdom_Midazolam_and_Euthanasia_in_the_COVID-19_Pandemic Citation: Wilson Sy (2024) Excess Deaths in the United Kingdom: Midazolam and Euthanasia in the COVID-19 Pandemic. Medical & Clinical Research, 9(2), 01-21. Macro-data during the COVID-19 pandemic in the United Kingdom (UK) are shown to have significant data anomalies and inconsistencies with existing explanations. England 2020 UK spike in deaths, wrongly attributed to COVID-19 in April 2020, was not due to SARS-CoV-2 virus, which was largely absent, but was due to the widespread use of Midazolam injections, which were statistically very highly correlated (coefficient over 90 percent) with excess deaths in all regions of England during 2020. Importantly Excess deaths remained elevated following mass vaccination in 2021, but were statistically uncorrelated to COVID injections, while remaining significantly correlated to Midazolam injections. The widespread and persistent use of Midazolam in UK suggests a possible policy of systemic euthanasia. Unlike Australia, where assessing the statistical impact of COVID injections on excess deaths is relatively straightforward, UK excess deaths were closely associated with the use of Midazolam and other medical intervention. The UK iatrogenic pandemic Caused by euthanasia deaths from Midazolam and also, likely caused by COVID injections, https://www.researchgate.net/publication/374261986_Early_Indication_of_Long-Term_Impact_of_COVID_Injections but their relative impacts are difficult to measure from the data, due to causal proximity of euthanasia. Global investigations of COVID-19 epidemiology, based only on the relative impacts of COVID disease and vaccination, may be inaccurate, due to the neglect of significant confounding factors in some countries.

Are the Covid-19 drugs produced by Pfizer and Moderna GMOs or genetically modified organisms? https://julesonthebeach.substack.com/p/zee-fda-had-zee-science-but-intentionally https://www.givesendgo.com/GAVAZ An Australian Federal Court case has evidence to say they are GMOs Case File Number: VID510/2023 Dr Julian Fidge v. Pfizer Australia Pty Ltd & Moderna Pty Ltd Dr Fidge is an Australian medical doctor and trained pharmacist. The case has been brought under the Australian Gene Technology Act 2000 Section 10 of Gene Technology Act defines what a Genetically Modified Organism (GMO) is. First, an Organism is: ‘any biological entity’ ‘capable of transferring genetic material’ The Pfizer and Moderna Covid products contain LNP-modRNA complexes These complexes satisfy being called ‘any biological entity’ under the law The modRNA is genetic material The Lipid Nanoparticles or LNPs encapsulate the modRNA and together bio-distribute and transfer the LNP-modRNA complexes throughout the human body The LNPs then transfect and transfer the modRNA cargo across cell membranes to deliver the modRNA inside cells By moving the modRNA about the body and then into cells, the LNP-modRNA complexes physically transfer genetic material after injection So the Organism part of the GMO definition is satisfied by the physical mode of transport of the LNP-modRNA complexes The next part of the GMO legal definition is – a Genetically Modified Organism is: an organism that has been modified by gene technology The Gene Technology part requires showing: any technique for the modification of genes or other genetic material. Pfizer and Moderna admit they modify genes to create modified RNA or modRNA for their products The MHRA, EMA, FDA, and TGA when approving the Covid-19 products recognised Pfizer and Moderna use modified nucleosides for the modRNA In the TGA Australian approval for Pfizer for example, the TGA notes: The Pfizer-BioNTech COVID-19 vaccine, BNT162b2 mRNA (tradename Comirnaty), comprises a nucleoside-modified messenger RNA (modRNA) encoding the viral spike glycoprotein (S) of SARS-CoV-2. Pfizer and Moderna create their modified nucleosides in the lab using recombinant techniques So the Gene Technology part of the GMO legal definition is also satisfied This means the Pfizer and Moderna Covid-19 products satisfy the Australian legal definitions for being properly called GMOs Under the Australian Gene Technology Act anyone who ‘deals’ with a GMO in Australia must be regulated under a GMO licence Pfizer and Moderna failed to apply for GMO licences in Australia Dealing with GMOs in Australia without a GMO licence is a serious criminal offense under Section 32 of the Gene Technology Act 2000 In fact the boss of Australia’s Office of the Gene Technology Regulator, or OGTR, recently admitted to an Australian Senate Committee that both the Pfizer and Moderna products are GMOs No Australian was told by the OGTR or the TGA that they were being asked to receive Genetically Modified Organisms or GMOs when getting a Covid-19 injection This is not just an Australian GMO legal issue In the United Kingdom Genetically Modified Organisms are dealt with under the Environmental Protection Act 1990 and specifically Section 106 under Part VI The United Kingdom legal definitions for what is regarded as a GMO is almost identical to the Australian legal definitions we just looked at Like in Australia, the United Kingdom requires new GMOs to be subjected to an extensive Risk Assessment Even after an extensive Risk Assessment the United Kingdom Secretary of State still has to provide a Consent before a GMO can be introduced into the United Kingdom The MHRA knew United Kingdom GMO legal definitions applied to Pfizer and Moderna because it is their job to know and they have GMO experts But both Pfizer and Moderna applied for marketing approvals under the Human Medicines Regulations 2012 which exempted them from having to undergo a GMO Risk Assessment for their Covid-19 products And because of that exemption neither company had to mention on the Product Information that their products contain GMOs even though they satisfy the legal definitions

Original video link https://parliamentlive.tv/Event/Index/168f642a-5708-4b1a-9857-d8eacf475252 Hansard link https://hansard.parliament.uk/Commons/2024-04-18/debates/9F01F787-D758-43D4-B8D1-4FA357EB3EED/Covid-19ResponseAndExcessDeaths We know, by all the different measures, that many more people are dying now than were before the pandemic. In particular, the impact on people’s hearts, and increasingly younger people’s hearts, deserves attention. The British Heart Foundation reported last June that since the start of the pandemic, 100,000 more people have died than would have been expected. That is surely significant cause for us to take this question seriously. We know that there are adverse effects from the vaccination. Everybody acknowledges that; it is a question of the extent to which those effects have been manifested. I am afraid, is that the MHRA is significantly deficient in the way it operates. The Cumberlege report—this was referenced in the earlier debate—raised concerns about the way treatments are regulated and licensed that have not yet been addressed. I am afraid that through the covid episode many of the same concerns were manifested in relation to the vaccines. We now know that the MHRA knew about the effect of the AstraZeneca vaccine on blood clotting as early as February 2021, but issued a warning about that only some months later—in April, a month after other countries had suspended the AZ vaccine. The MHRA also knew about the prevalence of heart problems and myocarditis in February 2021 but did nothing about it until June that year. In the intervening time, millions of people were vaccinated without the knowledge that the MHRA had. As has been said, we found out recently that Pfizer misrepresented the safety and efficacy of the vaccine. There has been very little comeback against it for that, and no meaningful fine. As we heard, just a few thousands pounds were charged in expenses. The regulatory system that oversees the pharmaceutical companies is surely deeply conflicted, not least due to being partly funded by the pharmaceutical companies that it was set up to represent. It is significant and of concern that they have made so much money out of the vaccines, and so far do not appear to be making due recompense for some of the acknowledged harms— I am not talking about the wilder claims—that their vaccines have been responsible for. Will the Minister enlighten us on whether the indemnities against civil and Government action that the Government awarded to the vaccine manufacturers at the beginning of the production process still apply if it transpires that the companies misled the Government and the public about the safety and efficacy of their product? The inquiry has been mentioned. There are so many unanswered questions and apparent red flags that it surprises me that the media and Parliament are not more up in arms about excess deaths. I am surprised that more attention is not being paid to this question. The fact is that this scandal—if it is a scandal—suits no one in high places in our country. It is true that we have an inquiry, but as the hon. Member for Blackley and Broughton said, surely it is asking the wrong questions. It is very concerning that the module looking at the vaccination programme has been postponed. It strikes me that the inquiry is essentially asking the wrong questions; it is really just asking why we did not do more lockdowns quicker. That seems to be its prevailing question for the experts—not whether the whole response was the right one, and crucially, in the light of what we now know, whether the final response of a mass vaccination programme was as safe and effective as was claimed. We are rightly proud in this country of the effectiveness, speed and operation of the vaccine production and roll-out. It was a triumph of effective collaboration between Government and the private sector. The operation of the roll-out was a victory that all people can acknowledge, but it is not enough to say that the roll-out was done well. Was it done safely? Did it need to be done on the scale on which it was done? Particularly, did young people need to be vaccinated at all? We all remember Kate Bingham and others saying early on that the vaccine was only for the older population. These questions are increasingly being asked by the public and raised in the media. Let me conclude quickly with what I have been doing. I hope that we will get more answers from the Minister than I have had so far from the Government. On 17 April 2023—a year ago yesterday—I wrote privately to the Secretary of State, asking him for evidence that justified the Government’s assertion that there was no link between the vaccines and the excess deaths. I did that because I had so much correspondence from people raising that concern.

Get your copy of Topher's book at: www.goodpeoplebreakbadlaws.com Watch the full Battleground Melbourne Documentary for FREE at: www.battlegroundmelbourne.com Follow Topher Field on all his social media platforms via: @topherfield on Youtube, Facebook, X, Instagram, Rumble, and more! Join Topher's email list via: www.topherfield.net

Direct links to Marc’s book and substack Amazon.com (USA) https://www.amazon.com/NEEDLES-SECRET-UNRAVELING-MYSTERY-REVOLUTION/dp/B0CYLSCMHN/ref=cm_cr_arp_d_product_top?ie=UTF8 UK Amazon https://www.amazon.co.uk/NEEDLES-SECRET-UNRAVELING-MYSTERY-REVOLUTION/dp/B0CYLSCMHN/ref=cm_cr_arp_d_product_top?ie=UTF8 Australia Amazon https://www.amazon.com.au/NEEDLES-SECRET-UNRAVELING-MYSTERY-REVOLUTION/dp/B0CYLSCMHN/ref=cm_cr_arp_d_product_top?ie=UTF8 The Bolus Theory Series on Substack https://covidmythbuster.substack.com My Bolus Theory website https://marcgirardot.com

The spike protein exhibits pathogenic characteristics https://www1.racgp.org.au/ajgp/2024/april/long-covid-sufferers-can-take-heart?fbclid=IwAR0_LO6qgqBlf-Of5kix-wpuAVmNDtk1tYm4LJyIx-Rvn3SeFbEDGo3bK0c Multiple studies have shown an increased risk of myocarditis after vaccination with mRNA encoding SARS-CoV-2 spike protein. mRNA vaccines can result in spike protein expression in Muscle tissue Lymphatic system Cardiomyocytes Other cells after entry into the circulation. There is concern that COVID-19 vaccination per se might contribute to long COVID, giving rise to the colloquial term ‘Long Vax(x)’ https://pubmed.ncbi.nlm.nih.gov/35084966/ The spike protein of SARS-CoV-2 exhibits pathogenic characteristics and is a possible cause of post-acute sequelae, after SARS-CoV-2 infection or COVID-19 vaccination. COVID-19 vaccines utilise a modified, stabilised prefusion spike protein that might share similar toxic effects with its viral counterpart. https://pubmed.ncbi.nlm.nih.gov/38024037/ Not the natural Uridine Uracil is one of the four nucleobases in RNA Adenine, cytosine, guanine The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600071/ Both consisted of N1-methyl-pseudouridine-modified mRNA encoding the SARS-COVID-19 Spike protein and were delivered with a lipid nanoparticle (LNP) formulation A possible association between COVID-19 vaccination and the incidence of POTS has been demonstrated in a cohort of 284,592 COVID-19-vaccinated individuals Postural tachycardia syndrome (PoTS) is when your heart rate increases very quickly after getting up from sitting or lying down. https://www.nhs.uk/conditions/postural-tachycardia-syndrome/ Recipients of two or more injections of the mRNA vaccines display a class switch to IgG4 antibodies. https://pubmed.ncbi.nlm.nih.gov/37243095/ Abnormally high levels of IgG4 Might cause autoimmune diseases Promote cancer growth Autoimmune myocarditis Other IgG 4-related diseases There are clear implications for vaccine boosting where these and similar observations, relating to COVID-19 vaccination and the incidence of long COVID-like symptoms are substantiated, adding further to public health officials’ concerns. Understanding the persistence of viral mRNA, and viral protein and their cellular pathological effects after vaccination with and without infection is clearly required. Because COVID-19 vaccines were approved without long-term safety data and might cause immune dysfunction, it is perhaps premature to assume that past SARS-CoV-2 infection is the sole common factor in long COVID. Millions worldwide experience post-acute sequelae of COVID-19 (PASC or long COVID) Although the Australian Bureau of Statistics and other health agencies in Australia do not survey the prevalence of long COVID, it is estimated that it affects hundreds of thousands Long COVID is a heterogeneous disease with variable cardiac, pulmonary, haematological and neurological involvement There is no consensus on what causes lingering COVID-19 symptoms long after the acute infection has cleared. Often unable to secure a diagnosis, patients are wont to seek multiple serial medical opinions, frequently being told their condition is due to anxiety or post-pandemic mental issues.

Professor Angus Dalgleish, (Fellow of the Royal College of Physicians, Fellow of the Royal College of Pathologists, Fellow of medical Science.) Professor Dalgleish is a highly experienced doctor, physician, medical teacher, medical author and researcher with over 500 primary research publications. He was also a pioneering researcher into HIV/AIDS. Here we discuss the recently observed changes in cancer presentations and deaths. Some of the discussion considers this research paper noting excess cancer deaths in Japan. Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan https://www.cureus.com/articles/196275-increased-age-adjusted-cancer-mortality-after-the-third-mrna-lipid-nanoparticle-vaccine-dose-during-the-covid-19-pandemic-in-japan#!/ Gibo M, Kojima S, Fujisawa A, et al. (April 08, 2024) Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan. Cureus 16(4): e57860. DOI 10.7759/cureus.57860 Conclusions Statistically significant increases in age-adjusted mortality rates of all cancer and some specific types of cancer, namely, ovarian cancer, leukemia, prostate, lip/oral/pharyngeal, pancreatic, and breast cancers, were observed in 2022 after two-thirds of the Japanese population had received the third or later dose of SARS-CoV-2 mRNA-LNP vaccine. These particularly marked increases in mortality rates of these ERα-sensitive cancers may be attributable to several mechanisms of the mRNA-LNP vaccination, rather than COVID-19 infection itself or reduced cancer care due to the lockdown. Researchers have reported that the SARS-CoV-2 mRNA-LNP vaccine may pose the risk of development and progression of cancer. Several case reports have described cancer developing or worsening after vaccination and discussed possible causal links between cancer and mRNA-LNP vaccination.

Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan https://www.cureus.com/articles/196275-increased-age-adjusted-cancer-mortality-after-the-third-mrna-lipid-nanoparticle-vaccine-dose-during-the-covid-19-pandemic-in-japan#!/ Gibo M, Kojima S, Fujisawa A, et al. (April 08, 2024) Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan. Cureus 16(4): e57860. DOI 10.7759/cureus.57860 Conclusions Statistically significant increases in age-adjusted mortality rates of all cancer and some specific types of cancer, namely, ovarian cancer, leukemia, prostate, lip/oral/pharyngeal, pancreatic, and breast cancers, were observed in 2022 after two-thirds of the Japanese population had received the third or later dose of SARS-CoV-2 mRNA-LNP vaccine. These particularly marked increases in mortality rates of these ERα-sensitive cancers may be attributable to several mechanisms of the mRNA-LNP vaccination, rather than COVID-19 infection itself or reduced cancer care due to the lockdown. Researchers have reported that the SARS-CoV-2 mRNA-LNP vaccine may pose the risk of development and progression of cancer. Several case reports have described cancer developing or worsening after vaccination and discussed possible causal links between cancer and mRNA-LNP vaccination. Details of the paper No significant excess mortality was observed during the first year of the pandemic (2020). However, some excess cancer mortalities were observed in 2021 after mass vaccination with the first and second vaccine doses, and significant excess mortalities were observed for all cancers and some specific types of cancer after mass vaccination with the third dose in 2022. During the COVID-19 pandemic Excess deaths including cancer have become a concern in Japan Study aimed to evaluate how age-adjusted mortality rates (AMRs) for different types of cancer in Japan changed during the COVID-19 pandemic (2020-2022). Official statistics from Japan, used to compare observed annual and monthly AMRs, with predicted rates based on pre- pandemic (2010-2019) figures In 2020 (first year of the pandemic) Significant deficit mortality for all causes, and no excess mortality for all cancers. In 2021 Significant excess mortality of 2.1% for all causes, and 1.1% for all cancers. In 2022 Excesses mortality, 9.6% 2.1% for all cancers Number of excess deaths 115,799 Number of excess cancer deaths, 7,162 Lung, colorectal, stomach, pancreatic, and liver cancer Accounted for 61% of deaths from all cancers. AMRs for the four cancers with the most deaths showed a decreasing trend until the first year of the pandemic in 2020, but the rate of decrease slowed in 2021 and 2022. Since February 2021, the mRNA-lipid nanoparticle (mRNA-LNP) vaccine has been available for emergency use, and is recommended for all aged six months and older As of March 2023 80% of the Japanese population had received first and second doses, 68% had received third dose, 45% had received fourth dose Excess deaths from causes other than COVID-19 have been reported in various countries, including deaths from cancer, and Japan is no exception Japan, good data Large population of 123 million Availability of official statistics 80% accuracy rate of death certificates according to autopsy studies Vaccination rates by age group, the websites of the Prime Minister's Office and the Ministry of Health, Labor and Welfare Discussion All cancer deaths: A statistically significant excess emerged in 2021 and increased further in 2022. In addition, significant excess monthly mortality was observed after August 2021, whereas mass vaccination of the general population began around April 2021. There were excess trends in cancer deaths across most age groups. The significant increases in mortalities for six specific cancer types were unlikely to be explained by a shortage of healthcare services.

Interview with leading researcher James Roguski on the new international health regulations from the WHO. Follow James on Substack, https://substack.com/@jamesroguski

Pfizer, bringing discredit to pharmaceutical industry https://www.pmcpa.org.uk/media/cwvkqvyz/3741-case-report-28-march-2024.pdf https://www.telegraph.co.uk/news/2024/04/06/pfizer-breached-regulatory-code-five-times-watchdog-finds/ Senior executives used social media to promote an “unlicensed” Covid vaccine. Pfizer found to have breached the regulatory code five times, Prescription Medicines Code of Practice Authority (PMCPA) Pharmaceutical watchdog, relates to a complaint about a message posted on twitter November 2020 by senior Pfizer employees. COMPLAINT the complainant alleged that it turned out that such misbehaviour was even more widespread than they had thought, extended right to the top of their UK operation and was apparently continuing to this very day. PANEL RULING The Panel noted Pfizer’s submission that on further investigation into this complaint four other Pfizer UK colleagues, including another senior colleague in the UK organisation, had re-tweeted the same post. The Panel queried whether a social media platform, such as Twitter was the appropriate forum to share such information. The Panel noted the tweet contained limited information regarding the efficacy of the vaccine candidate with no safety information provided. On the balance of probabilities, it was likely that the Pfizer UK employee’s connections would include UK members of the public as well as UK health professionals. The Panel noted that the tweet clearly referred to the outcome of the Pfizer and BioNTech’s vaccine being developed to protect against COVID-19. The Panel noted that Clause 3.1 prohibited the promotion of a medicine prior to the grant of its marketing authorisation. They must not mislead either directly or by implication, by distortion, exaggeration or undue emphasis. Material must be sufficiently complete to enable the recipient to form their own opinion of the therapeutic value of the medicine. It must not be stated that a product has no adverse reactions, toxic hazards or risks of addiction or dependency. The Panel noted the tweet made no reference to adverse events and was therefore concerned that important safety information relating to the vaccine candidate was not provided and ruled a breach of Clause 7.9 of the 2019 Code as acknowledged by Pfizer. The Panel noted Pfizer stated that the senior employee whose re-tweet was the subject of this complaint had completed the social media training module in October 2019. Activity which was clearly outside of company policy had not been taken down or deleted. ‘Unlicensed medicine proactively disseminated’ “unlicensed medicine being proactively disseminated on Twitter to health professions and members of the public in the UK”.

Vitamin D supplementation has a protective effect, against the incidence of COVID-19 in RCT studies, OR 0.403, (95% IC 0.218, 0.747) In the RCTs performed on HCWs, the overall reduction in risk in the population supplemented with vitamin D was approximately 80% Against the incidence of COVID-19 in analytical studies OR = 0.592, (95% IC 0.476–0.736) Against the incidence of COVID-19 ICU admission OR 0.317, (95% IC 0.147–0.680). Our meta-analysis suggests a definitive and significant association between the protective role of vitamin D and COVID-19 incidence and ICU admission. Preventive Vitamin D Supplementation and Risk for COVID-19 Infection: A Systematic Review and Meta-Analysis https://www.mdpi.com/2072-6643/16/5/679 (28th Feb 2024) Vitamin D, crucial roles Bone homeostasis, muscle function, oncogenesis, immune response and metabolism. In the context of the COVID-19 Numerous researchers have tried to determine the role vitamin D in the immune response to the virus. Systematic review and meta-analysis, 15th May 2023 Preventive vitamin D supplementation, 16 publications N = 1,262,235 participants, A protective role in Incidence of COVID-19 Mortality Admission to intensive care units (ICUs). We calculated the Odds Ratios The assessment of potential bias and the evaluation of study quality will be conducted independently by two researchers. Extra information The majority of the effects of vitamin D are mediated by the VDR, which promotes the expression of genes containing specific DNA sequences and is expressed in almost all nucleated cells Approximately 3 percent of the human genome is under the control of 1,25-dihydroxyvitamin D Vitamin D has been observed to contribute to the synthesis of defensins, to be pivotal for enhancing the phagocytic activity, and to modulate the immune system response by regulating the inflammatory cascade

The spike protein of SARS-CoV-2 exhibits pathogenic characteristics. https://www1.racgp.org.au/ajgp/2024/april/long-covid-sufferers-can-take-heart?fbclid=IwAR0_LO6qgqBlf-Of5kix-wpuAVmNDtk1tYm4LJyIx-Rvn3SeFbEDGo3bK0c Multiple studies have shown an increased risk of myocarditis after vaccination with mRNA encoding SARS-CoV-2 spike protein. mRNA vaccines can result in spike protein expression in Muscle tissue Lymphatic system Cardiomyocytes Other cells after entry into the circulation. There is concern that COVID-19 vaccination per se might contribute to long COVID, giving rise to the colloquial term ‘Long Vax(x)’ https://pubmed.ncbi.nlm.nih.gov/35084966/ The spike protein of SARS-CoV-2 exhibits pathogenic characteristics and is a possible cause of post-acute sequelae, after SARS-CoV-2 infection or COVID-19 vaccination. COVID-19 vaccines utilise a modified, stabilised prefusion spike protein that might share similar toxic effects with its viral counterpart. https://pubmed.ncbi.nlm.nih.gov/38024037/ Not the natural Uridine Uracil is one of the four nucleobases in RNA Adenine, cytosine, guanine The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600071/ Both consisted of N1-methyl-pseudouridine-modified mRNA encoding the SARS-COVID-19 Spike protein and were delivered with a lipid nanoparticle (LNP) formulation A possible association between COVID-19 vaccination and the incidence of POTS has been demonstrated in a cohort of 284,592 COVID-19-vaccinated individuals Postural tachycardia syndrome (PoTS) is when your heart rate increases very quickly after getting up from sitting or lying down. https://www.nhs.uk/conditions/postural-tachycardia-syndrome/ Recipients of two or more injections of the mRNA vaccines display a class switch to IgG4 antibodies. https://pubmed.ncbi.nlm.nih.gov/37243095/ Abnormally high levels of IgG4 Might cause autoimmune diseases Promote cancer growth Autoimmune myocarditis Other IgG 4-related diseases There are clear implications for vaccine boosting where these and similar observations, relating to COVID-19 vaccination and the incidence of long COVID-like symptoms are substantiated, adding further to public health officials’ concerns. Understanding the persistence of viral mRNA, and viral protein and their cellular pathological effects after vaccination with and without infection is clearly required. Because COVID-19 vaccines were approved without long-term safety data and might cause immune dysfunction, it is perhaps premature to assume that past SARS-CoV-2 infection is the sole common factor in long COVID. Millions worldwide experience post-acute sequelae of COVID-19 (PASC or long COVID) Although the Australian Bureau of Statistics and other health agencies in Australia do not survey the prevalence of long COVID, it is estimated that it affects hundreds of thousands Long COVID is a heterogeneous disease with variable cardiac, pulmonary, haematological and neurological involvement There is no consensus on what causes lingering COVID-19 symptoms long after the acute infection has cleared. Often unable to secure a diagnosis, patients are wont to seek multiple serial medical opinions, frequently being told their condition is due to anxiety or post-pandemic mental issues. The median duration of long COVID symptoms is five months, but 10% of patients still experience symptoms at 12 months. Fatigue, shortness of breath and difficulty concentrating are reported at least up to two years after SARS-CoV-2 infection. It is still too early to say whether some individuals with long COVID might never recover. Long COVID patients present elevated inflammatory biomarkers, (eg interleukin-6, C-reactive protein, tumour necrosis factor-α) Those subscribing to long COVID digital support groups report months of frustration at not being listened to, finding the health system woefully inadequate, with few primary or secondary care professionals knowing enough to offer much. The outcome for some of those experiencing long COVID is self-prescribed medication using over-the-counter remedies and dietary changes based on potentially conflicting or misleading online information. Some speak of a substantial proportion of their income being used in this way. In Australia, an estimated 240,000 of those with long COVID no longer work full time. Work absenteeism might significantly impact the nation’s economy, as in the UK. In the US, long COVID has been declared a national emergency. https://pubmed.ncbi.nlm.nih.gov/36219031/ Reduced to working part time to cope with unwellness, those with long COVID commonly report having to wait a year or more before receiving a diagnosis.

Dr. Melissa McCann is a general practitioner in Queensland, Australia Crowdfunding page- https://www.nomoresilenceau.com/campaigns/covid-vaccine-class-action-injuries/ The speech that caused all my Medical Board woes - https://rumble.com/v2bk5mw-dr-melissa-mccann-speech-covid-vaccines-and-effects-tour-sydney-australia-2.html A video summary of the class action claims- https://youtu.be/1i1RlGqKRlY?feature=shared The class action website including link to join – www.covidvaxclassaction.com.au

Professor Angus Dalgleish, mRNA Vaccines Must Be Banned Once and For All https://dailysceptic.org/2023/10/01/mrna-vaccines-must-be-banned-once-and-for-all/ https://www.conservativewoman.co.uk/mrna-vaccines-must-be-banned-once-and-for-all/ At the end of last year I reported that I was seeing melanoma patients who had been stable for years relapse after their first booster (their third injection). The number of my patients affected has been rising ever since. Other oncologists have contacted me from all over the world including from Australia and the U.S. After boosters The consensus is that it is no longer confined to melanoma but that increased incidence of: After boosters Lymphomas, a cancer of the lymphatic system Leukaemias, a group of cancers that affect the blood Kidney cancers My colorectal cancer colleagues report an epidemic of explosive cancers (those presenting with multiple metastatic spread in the liver and elsewhere). Those of us who knew from the beginning that the sequence of SARS-CoV-2 contained inserts which could not have possibly occurred naturally, and were similar to ones that had already been published from the Wuhan laboratory The ‘vaccine’ did not stay at the site of injection as promised Batch-to-batch variability These alarming concerns seem to have been brushed off by the regulators when they should have immediately begun investigating them in depth. Yellow Card and U.S. VAERS adverse event reports to be nothing to be worried about. DNA contamination So why are these cancers occurring? T cell suppression was my first likely explanation. However we must also now consider DNA plasmid and SV40 integration in promoting cancer development, Reports that mRNA spike protein binds p53 and other cancer suppressor genes. To advise booster vaccines, as is the current case, is no more and no less than medical incompetence. No ifs or buts any longer. All mRNA vaccines must be halted and banned now. Eurostat Circulatory diseases, cancer: 54% of all EU deaths in 2021 https://ec.europa.eu/eurostat/en/web/products-eurostat-news/w/DDN-20240325-2 In 2021 there were 5.3 million deaths in the EU Circulatory diseases, 1.71 million (32% of all deaths). Cancer, 1.14 million (22%). Respiratory diseases (0.32 million; 6%) Diseases of the digestive system (0.21 million; 4%) Eurostat, Excess deaths 2022 https://ec.europa.eu/eurostat/web/products-eurostat-news/-/ddn-20220916-1 April, + 12% May, +7% June, +7% July, + 16% Eurostat, 2023 https://ec.europa.eu/eurostat/web/products-eurostat-news/w/DDN-20230616-3 Excess mortality continued Eurostat, Jan 2024, + 3.6% In January 2024, the highest excess mortality rates were in the Netherlands (15.3 %), Denmark (11.5 %) and Germany (9.9 %). In January 2024, excess mortality continued to vary across the EU. Romania, Bulgaria, Hungary, Lithuania, Croatia, Luxembourg, Slovakia, Poland, Latvia and Czechia recorded no excess deaths.

Vitamin D supplementation has a protective effect, against the incidence of COVID-19 in RCT studies, OR 0.403, (95% IC 0.218, 0.747) In the RCTs performed on HCWs, the overall reduction in risk in the population supplemented with vitamin D was approximately 80% Against the incidence of COVID-19 in analytical studies OR = 0.592, (95% IC 0.476–0.736) Against the incidence of COVID-19 ICU admission OR 0.317, (95% IC 0.147–0.680). Our meta-analysis suggests a definitive and significant association between the protective role of vitamin D and COVID-19 incidence and ICU admission. Preventive Vitamin D Supplementation and Risk for COVID-19 Infection: A Systematic Review and Meta-Analysis https://www.mdpi.com/2072-6643/16/5/679 (28th Feb 2024) Vitamin D, crucial roles Bone homeostasis, muscle function, oncogenesis, immune response and metabolism. In the context of the COVID-19 Numerous researchers have tried to determine the role vitamin D in the immune response to the virus. Systematic review and meta-analysis, 15th May 2023 Preventive vitamin D supplementation, 16 publications N = 1,262,235 participants, A protective role in Incidence of COVID-19 Mortality Admission to intensive care units (ICUs). We calculated the Odds Ratios The assessment of potential bias and the evaluation of study quality will be conducted independently by two researchers. Extra information The majority of the effects of vitamin D are mediated by the VDR, which promotes the expression of genes containing specific DNA sequences and is expressed in almost all nucleated cells Approximately 3 percent of the human genome is under the control of 1,25-dihydroxyvitamin D Vitamin D has been observed to contribute to the synthesis of defensins, to be pivotal for enhancing the phagocytic activity, and to modulate the immune system response by regulating the inflammatory cascade

To be reported to the UK police. Read the full letter here, https://twitter.com/JimFergusonUK/status/1765289139677618585/photo/1

Health Secretary urged to release data that ‘may link Covid vaccine to excess deaths’ MPs and peers criticise ‘wall of silence’ Tweet from Andrew Bridgen https://twitter.com/ABridgen Health Secretary urged to release data that ‘may link Covid vaccine to excess deaths’ MPs and peers criticise ‘wall of silence’ https://www.telegraph.co.uk/news/2024/03/02/health-secretary-release-data-covid-vaccine-excess-deaths/ MPs and peers have accused the Health Secretary of withholding data that could link the Covid vaccine to excess deaths A cross-party group “growing public and professional concerns” UK’s rates of excess deaths since 2020 Demand to be shown the underlying data for to support the Government’s assertion, “no evidence” linking excess deaths to the vaccines for Covid-19. 21 MPs and peers “If those data do indeed exist, please share them; if thorough investigations have already ruled out such a link, please share the relevant reports,” “There is no place here for blind faith.” Written to Health Secretary Department of Health and Social Care (DHSC) Medicines and Healthcare products Regulatory Agency (MHRA) UK Health Security Agency (UKHSA) Potentially critical data, which maps the date of people’s Covid vaccine doses to the date of their deaths, have been released to pharmaceutical companies but not put into the public domain. Data should be released “on the same anonymised basis that it was shared with the pharmaceutical groups, and there seems to be no credible reason why that should not be done immediately”. “Questions about these trends, however, have to date been met by a relative wall of silence from your organisations and other public health officials.” A DHSC spokesman “We are committed to data transparency and publish a wide range of data on excess mortality. The datasets published are kept under constant review.”

Buy Dr David Grimes' bok here, https://yorkbookshop.com/health-and-personal-development/307-vitamin-d-deficiency-and-covid-19-its-central-role-in-a-world-pandemic.html

We feel compelled to conclude that the MHRA has indeed become an enabler for the pharmaceutical interests or patient safety industry, with patient safety no longer being its primary concern. Medicines regulator failed to flag Covid vaccine side effects, and must be urgently investigated. All-party parliamentary group, (APPG) on Pandemic Response and Recovery, believe MHRA were aware of heart and clotting issues, in February 2021, but did not highlight the problems for several months https://www.telegraph.co.uk/news/2024/02/27/mhra-covid-vaccine-side-effects-mps-all-party-parliamentary/ https://www.telegraph.co.uk/news/2023/03/05/esther-mcvey-covid-inquiry-lockdown-files-matt-hancock-baroness/ https://www.medscape.co.uk/viewarticle/uk-medicines-regulator-serious-risk-patient-safety-2024a10003cd?ecd=wnl_ret_240220_mscpmrk-GB_daily_etid6322343&uac=188254MN&impID=6322343&sso=true\ https://appgpandemic.org/news/mhra-letter-health-select-committee We write regarding serious concerns about the approach of the Medicines and Healthcare Products Regulatory Agency (MHRA), to patient safety and also problems in a system that, far from protecting patients, continues to put them at serious risk. Primodos, sodium valproate and pelvic mesh We also believe that the MHRA is at the heart of these far wider endemic failings, and that those cited in this letter merely represent the tip of a sizeable iceberg of failure. The Yellow Card Scheme The Yellow Card Scheme … is failing patients. Hospital admissions are caused or complicated by ADRs (16.5%), while analysis of in patient stays has shown that 15% of patients experience one or more ADRs, with half being either definitely or possibly avoidable. Independent Medicines and Medical Devices Safety Review Review, report First Do No Harm: We heard about a system that cannot be relied upon to identify promptly significant adverse outcomes arising from a medication or device, it is clear that there is gross under-reporting, and our complaints systems are both too complex and too diffuse to allow early signal detection. Under-reporting hinders the ability to detect signals and assign causation. The cost to patient safety of such an unreliable system can be measured in the needless fatalities, the considerable burden on the quality of life for survivors, and a £2.2 billion strain on NHS England alone. Only one in 12 patients are aware that they can report a suspected ADR. A 2006 systemic review https://pubmed.ncbi.nlm.nih.gov/16689555/ The rate of under-reporting of adverse events was, on average, 94% and possibly as high as 98%, meaning possibly only two in every 100 ADRs were reported to the MHRA. For example, a survey of UK pharmacists suggested they lack interest in, and do not promote, direct patient reporting. Only 19% of the respondents displayed a poster promoting the Yellow Card Scheme in their pharmacy. 2023, analysis of anticoagulants https://pubmed.ncbi.nlm.nih.gov/37269441/ Reporting of gastrointestinal bleeds North West of England Hospital Trust recorded 12,013 bleed-related emergency admissions. Of these, 1,058 were taking DOAC anticoagulants. Only six DOAC Yellow Card reports (0.56% of the possible) were made by the Trust during the period. Conflicts of Interest and Transparency From FDA to MHRA: are drug regulators for hire? https://www.bmj.com/content/377/bmj.o1538 The regulator-industry revolving door Proportion of covid-19 vaccine committee members that declared financial COIs UK, HMRA, 32% Australia, TGA, 50% March 2022, Dame June Raine, Chief Executive of the MHRA agency’s transition from “the watchdog to the enabler” does little to quell suspicions of conflicts and the implications for patient safety and cannot be overlooked. MHRA’s responses to Freedom of Information (FOI) requests. Between 2008 and 2017, only 41% of requests were successful. Since 2019, the number of requests has seen a substantial increase from 609 to 1,609 in 2021, likely due to concerns about the regulation of Covid-19 vaccinations, with 76% of these requests answered outside the 20 working days statutory response time. Often exemptions were applied or vague or evasive responses were received. The Medicines and Healthcare products Regulatory Agency from regulatory approval to post marketing pharmacovigilance the MHRA has a history of failing patients The MHRA does not attempt to assess or compare the safety of different vaccines MHRA “does not hold a process for the investigation and follow up of individual Yellow Card reports” MHRA only followed up some 54% of deaths reported in yellow cards as possibly linked to exposure to one of the Covid-19 vaccines. Two months later, 7 May, (2021) the MHRA withdrew AZ for under 40s, but only after further needless deaths What conclusions are we to draw about the seeming unwillingness of a regulator, largely funded by those it regulates, to disclose data to the same public it professes to protect? We feel compelled to conclude that the MHRA has indeed become an enabler for the pharmaceutical industry, with patient safety no longer being its primary concern.

https://lighthousedeclaration.org/declaration/ Ros Nealon-Cook, a psychologist from Australia, had her license suspended for sounding the alarm about the harms to children from government pandemic policy. Ros has joined forces with a number health professionals from around the world who were similarly censored and silenced. Together, they have created The Cape Byron Lighthouse Declaration to raise awareness about the widespread propaganda and censorship of expert scientific opinion. You can read and sign the declaration here: www.lighthousedeclaration.world – adding your signature will take less than a minute. In the coming months, the Lighthouse Declaration team will host a series of webinars and roundtables to further expand the conversation on these critical issues. Ros and the Lighthouse Declaration team, can be contacted through their social media channels or via the website: Twitter: @Lighthouse_Dec Twitter: @rosalina_nc Facebook: LighthouseDeclaration Instagram: @lighthouse_dec